Social Media Ideas for Big Pharma

<![CDATA[2026 Pharm Exec Top 50 Companies]]>

Big Pharma's Future Growth Rests on Chinese Science? Expert Says: 'We Can't Ban Our Way Out of This'

<![CDATA[Pharma’s New Growth Equation: Smarter Deals, Stronger Science, Rising Costs]]>

<![CDATA[Pharmaceutical Executive Daily: Pharm Exec Ranks Top 50 Companies of 2026]]>

<![CDATA[Taking a Hard Look at Pharma's Traditional Margin Model]]>

<![CDATA[Your Questions Answered: The Biggest Pharma and Biotech Stories This Week]]>

SA Asks: What's the outlook for Big Pharma M&A?

<![CDATA[ Eli Lilly to Acquire Merida Biosciences for $2.8 Billion ]]>

<![CDATA[Pharmaceutical Executive Daily: Nine Companies Strike Deals for MFN Pricing]]>

How Obamacare Pushes Big Pharma To Overcharge You For Prescriptions

I found out firsthand: big conglomerates make profits by keeping the system complicated, bureaucratic, and opaque.

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Enters $2.8 Billion Agreement to Acquire Merida Biosciences]]>

How the machine runs

Learn how pharma companies build durable businesses through doctors, sales networks and chronic therapies, and why regulatory risks can change fortunes overnight.

Biotech deals surge to record as fear of missing out grips Big Pharma

Prospect of patents expiring on lucrative drugs prompts drugmakers to hunt for next blockbuster medicines

<![CDATA[When Drug Pricing Becomes Trade Policy]]>

AstraZeneca and Bristol-Myers: when Big Pharma isn’t big enough

Sheer mass helps when enlarged balance sheets allow for bigger bets on potential blockbuster drugs

<![CDATA[Insilico Medicine Enters $2.5 Billion Alliance with Bora Pharmaceuticals ]]>

<![CDATA[CSPC Pharmaceutical & AstraZeneca Form Joint Venture for Biologics Manufacturing in China]]>

Trump wants Big Pharma to split MMR vaccine; Big Pharma thinks it's idiotic

It took just hours for the leading pharma group to reject the recommendations.

Pharma Looks to Cash in on Psychedelics as Patients Seek Alternatives to Psychotropic Drugs for Depression

Eli Lilly’s multibillion-dollar acquisition of a company that makes experimental psychedelic therapies marks the largest investment yet by a drugmaker in psychedelic medicine as a...

<![CDATA[The Retailization of Medicare Advantage: What Costco’s Entry Means for Pharma]]>

Amazon Pharmacy Executive: Formularies are Anti-Choice

Tanvi Patel, vice president and general manager of Amazon Pharmacy, and her co-panelists at the recent Bullseye event, explained why PBMs, payers and doctors are all hampering cons...

<![CDATA[Amazon Pharmacy Launches GLP-1 Delivery Service ]]>

<![CDATA[The Structural Problems Causing the Pharma and Biotech Industries’ Compliance Failures]]>

<![CDATA[Eli Lilly Surpasses Wall Street Estimates on Injectable GLP-1 Drugs]]>